PortfoliosLab logoPortfoliosLab logo
AUPH vs. VSEC
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

AUPH vs. VSEC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aurinia Pharmaceuticals Inc. (AUPH) and VSE Corporation (VSEC). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

AUPH vs. VSEC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AUPH
Aurinia Pharmaceuticals Inc.
-7.08%77.62%-0.11%108.10%-81.11%65.37%-31.74%197.07%50.55%115.71%
VSEC
VSE Corporation
6.78%82.26%47.93%39.19%-22.35%59.55%2.54%28.56%-37.81%25.45%

Fundamentals

Market Cap

AUPH:

$2.06B

VSEC:

$4.20B

EPS

AUPH:

$2.06

VSEC:

$1.55

PE Ratio

AUPH:

7.19

VSEC:

118.65

PEG Ratio

AUPH:

0.00

VSEC:

1.74

PS Ratio

AUPH:

7.29

VSEC:

3.55

PB Ratio

AUPH:

3.54

VSEC:

2.92

Total Revenue (TTM)

AUPH:

$283.06M

VSEC:

$1.11B

Gross Profit (TTM)

AUPH:

$250.39M

VSEC:

$91.90M

EBITDA (TTM)

AUPH:

$109.83M

VSEC:

$1.11B

Returns By Period

In the year-to-date period, AUPH achieves a -7.08% return, which is significantly lower than VSEC's 6.78% return. Over the past 10 years, AUPH has underperformed VSEC with an annualized return of 17.52%, while VSEC has yielded a comparatively higher 19.38% annualized return.


AUPH

1D
6.01%
1M
4.59%
YTD
-7.08%
6M
34.12%
1Y
84.33%
3Y*
10.58%
5Y*
2.44%
10Y*
17.52%

VSEC

1D
11.51%
1M
-18.79%
YTD
6.78%
6M
11.05%
1Y
54.11%
3Y*
61.04%
5Y*
36.39%
10Y*
19.38%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AUPH vs. VSEC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AUPH
AUPH Risk / Return Rank: 8989
Overall Rank
AUPH Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
AUPH Sortino Ratio Rank: 8686
Sortino Ratio Rank
AUPH Omega Ratio Rank: 8787
Omega Ratio Rank
AUPH Calmar Ratio Rank: 9393
Calmar Ratio Rank
AUPH Martin Ratio Rank: 9090
Martin Ratio Rank

VSEC
VSEC Risk / Return Rank: 7878
Overall Rank
VSEC Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
VSEC Sortino Ratio Rank: 7575
Sortino Ratio Rank
VSEC Omega Ratio Rank: 7272
Omega Ratio Rank
VSEC Calmar Ratio Rank: 7979
Calmar Ratio Rank
VSEC Martin Ratio Rank: 8686
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AUPH vs. VSEC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and VSE Corporation (VSEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AUPHVSECDifference

Sharpe ratio

Return per unit of total volatility

1.87

1.16

+0.71

Sortino ratio

Return per unit of downside risk

2.51

1.79

+0.72

Omega ratio

Gain probability vs. loss probability

1.36

1.22

+0.14

Calmar ratio

Return relative to maximum drawdown

4.95

2.14

+2.82

Martin ratio

Return relative to average drawdown

10.80

7.91

+2.89

AUPH vs. VSEC - Sharpe Ratio Comparison

The current AUPH Sharpe Ratio is 1.87, which is higher than the VSEC Sharpe Ratio of 1.16. The chart below compares the historical Sharpe Ratios of AUPH and VSEC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


AUPHVSECDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.87

1.16

+0.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

0.83

-0.80

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.24

0.42

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

0.16

0.27

-0.11

Correlation

The correlation between AUPH and VSEC is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

AUPH vs. VSEC - Dividend Comparison

AUPH has not paid dividends to shareholders, while VSEC's dividend yield for the trailing twelve months is around 0.22%.


TTM20252024202320222021202020192018201720162015
AUPH
Aurinia Pharmaceuticals Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VSEC
VSE Corporation
0.22%0.23%0.42%0.77%0.85%0.59%0.94%0.89%1.00%0.54%0.51%0.68%

Drawdowns

AUPH vs. VSEC - Drawdown Comparison

The maximum AUPH drawdown since its inception was -87.58%, which is greater than VSEC's maximum drawdown of -76.09%. Use the drawdown chart below to compare losses from any high point for AUPH and VSEC.


Loading graphics...

Drawdown Indicators


AUPHVSECDifference

Max Drawdown

Largest peak-to-trough decline

-87.58%

-76.09%

-11.49%

Max Drawdown (1Y)

Largest decline over 1 year

-15.91%

-27.40%

+11.49%

Max Drawdown (5Y)

Largest decline over 5 years

-87.58%

-47.58%

-40.00%

Max Drawdown (10Y)

Largest decline over 10 years

-87.58%

-76.09%

-11.49%

Current Drawdown

Current decline from peak

-55.20%

-19.04%

-36.16%

Average Drawdown

Average peak-to-trough decline

-49.17%

-30.75%

-18.42%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.29%

7.40%

-0.11%

Volatility

AUPH vs. VSEC - Volatility Comparison

The current volatility for Aurinia Pharmaceuticals Inc. (AUPH) is 12.90%, while VSE Corporation (VSEC) has a volatility of 16.82%. This indicates that AUPH experiences smaller price fluctuations and is considered to be less risky than VSEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


AUPHVSECDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.90%

16.82%

-3.92%

Volatility (6M)

Calculated over the trailing 6-month period

26.57%

33.60%

-7.03%

Volatility (1Y)

Calculated over the trailing 1-year period

45.34%

46.83%

-1.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

68.68%

43.85%

+24.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

74.42%

45.91%

+28.51%

Financials

AUPH vs. VSEC - Financials Comparison

This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and VSE Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
77.11M
301.18M
(AUPH) Total Revenue
(VSEC) Total Revenue
Values in USD except per share items